Search for: "Mylan Inc."
Results 181 - 200
of 674
Sorted by Relevance
|
Sort by Date
29 Jun 2011, 8:53 am
Inc., C.A. [read post]
9 May 2012, 8:57 pm
Mylan Pharmaceuticals Inc. [read post]
6 May 2012, 8:43 pm
Mylan Pharmaceuticals, Inc. 0:12-cv-60704; filed April 20, 2012 in the Southern District of Florida • Plaintiffs: Apotex,... [read post]
2 Mar 2022, 7:50 am
Mylan Pharmaceuticals Inc. [read post]
21 Aug 2018, 9:58 pm
Mylan Pharmaceuticals Inc., affirming the decision by the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
12 Aug 2013, 2:58 am
Mylan, Inc., No. 11 C 1285, Slip Op. [read post]
18 May 2012, 1:16 pm
Mylan Pharmaceuticals Inc., C.A. [read post]
5 Dec 2014, 4:02 am
Mylan Inc., No. 11 C 1285, Slip Op. [read post]
10 Mar 2013, 9:59 pm
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
13 Mar 2013, 4:05 pm
Mylan Technologies Inc., et al., C.A. [read post]
22 Oct 2013, 2:28 pm
Inc., et al., C.A. [read post]
30 Sep 2013, 8:12 am
On September 25, 2013, Mylan Inc. [read post]
21 Feb 2019, 12:11 pm
Mylan Pharma., Inc., available here. [read post]
The PTAB Puts Hatch-Waxman Defendants on Notice: File IPRs Early or Risk Fintiv Discretionary Denial
29 Oct 2020, 4:15 am
On September 16, 2020, the Patent Trial and Appeal Board (PTAB) denied institution of Mylan Labs Ltd. [read post]
4 Feb 2019, 8:59 am
Inc. v. [read post]
4 Sep 2016, 8:42 am
With the price increase of the live-saving EpiPen from $100 per two-pack to over $600 per two-pack last week (conveniently in August when most parents who have children with allergies are set to purchase their necessary supplies of the drug before school starts), the company responsible for the hike, Mylan Inc., is backing away fromThe post EpiPen Increase Based in Greed, Not Need appeared first on Legal Reader. [read post]
30 Jun 2018, 2:01 am
Mylan Pharmaceuticals Inc., Civil Action No. 17-389-RGA (D.Del. [read post]
14 Nov 2016, 2:01 pm
As previously reported, Mylan Inc., the pharmaceutical manufacturer of the life-saving EpiPen, misclassified their brand name drug as generic for years, thus deceiving and effectively defrauding governmentally-funded insurance providers Medicare and Medicaid, resulting in millions of dollars in overpayments by taxpayers, all in an effort to save themselves money prior to hiking the price of The post EpiFail: Gov’t Knew EpiPen Was Misclassified in 2009 appeared first on Legal… [read post]
29 Aug 2016, 5:02 am
Just last week, Mylan Inc. decided it was a good idea to raise the price of the life-saving EpiPen, which is used to stop a person from going into anaphylactic shock after experiencing an allergic reaction. [read post]
10 Nov 2022, 1:25 pm
The Securities and Exchange Commission today announced insider trading charges against Ramkumar Rayapureddy, Chief Information Officer of pharmaceutical company Viatris Inc., which was formerly known as Mylan N.V. [read post]
